By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


J.P. Morgan 

Phone: 212-270-6000 Fax:



Company News
JPM17: Why the Key to Gene Therapy Could be in an Old Bay Area Warehouse 1/13/2017 6:09:14 AM
JPM17: Opko Health (OPK) CEO's Gameplan After Its Recent Growth Hormone Failure 1/13/2017 6:02:06 AM
JPM17: For Medtronic (MDT), Old Data Habits Die Hard 1/12/2017 6:48:35 AM
JPM17: Kite Pharma (KITE)'s Strategy for Commercializing Its Lead CAR-T Drug 1/12/2017 6:44:40 AM
JPM17: Surprise! Pfizer (PFE) is Still Deal Hungry for M&As After Medivation (MDVN) 1/12/2017 5:56:20 AM
JPM17: Biotech IPO Guru Vivek Ramaswamy Expects More Startups, Deals in 2017 1/12/2017 5:49:52 AM
JPM17: CureVac Release: Biotech's mRNA Program Fails Phase II Test, Putting Spotlight on Other Biotechs Like Moderna 1/12/2017 5:45:05 AM
JPM17: Eli Lilly (LLY) Not Looking for a Mega-Merger But Stays Open to Other M&A Deals 1/11/2017 6:26:04 AM
JPM17: Sarepta (SRPT)'s New Numbers Impress Investors, Stock Gained $300 Million Overnight 1/11/2017 5:48:10 AM
JPM17: New Biogen (BIIB) CEO on Groundbreaking Alzheimer's Trial and the Company's Future 1/11/2017 5:32:53 AM